Skip to main content

Advertisement

Open Peer Review Reports for: Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
24 Nov 2011 Submitted Original manuscript
28 Nov 2011 Author responded Author comments - Charlotte Huijts
Resubmission - Version 2
28 Nov 2011 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
30 Nov 2011 Author responded Author comments - Charlotte Huijts
Resubmission - Version 4
30 Nov 2011 Submitted Manuscript version 4
Publishing
30 Nov 2011 Editorially accepted
30 Nov 2011 Article published 10.1186/1471-2407-11-505

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement